Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reinforcing Effects of Intranasal Buprenorphine vs Buprenorphine/Naloxone
NCT01760473Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- May 2009
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of v1003, naloxone in heroin dependence, sponsored by New York State Psychiatric Institute. Started May 2009; status: completed.
02
Drugs
v1003naloxone
03
Conditions
heroin dependence
Beyond the preview
Go deeper on NCT01760473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01760473.